In our November 2024 poll, PHSL asked, “What percent of trading partners do you expect to be prepared for implementation of the DSCSA requirements by November 2024?” Complete results are as follows:
- 0-20% prepared: 0 responses (0%)
- 21-40% prepared: 3 responses (27%)
- 41-60% prepared: 3 responses (27%)
- 61-80% prepared: 4 responses (37%)
- >80% prepared: 1 response (9%)
The majority of respondents expect that 61-80% of trading partners would be prepared for the implementation of the DSCSA requirements by November 2024. The overall expectations suggest a mixed but somewhat optimistic outlook.
The Drug Supply Chain Security Act (DSCSA) requires enhanced tracking of prescription drugs throughout the supply chain, aiming to improve safety and reduce counterfeit drugs. However, there are several DSCSA exemptions that may impact the preparedness of trading partners and could influence the expectations in the poll. PHSL has previously reported on these exemptions at the following links: